Nectar Lifesciences Limited

Web: neclife.com NSE: NECLIFE BSE: 532649 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

12 0(0%)

Volume

1L as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

26/100

Growth Score

60/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

236

No. of Shares

19.4

P/E

70.39

P/B

0.71

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

18-Jul-05

Promoter Holding

51.84%

FII Holding

0.5%

DII Holding

0.01%

Price Chart

Price Performance

1 Week2%

1 Month5%

3 Months11%

6 Months40%

1 Year40%

YTD44%

Moving Average

5 Day SMA12

10 Day SMA12

20 Day SMA12

30 Day SMA12

50 Day SMA13

61 Day SMA13

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	13	12	12	13
Resistance 2	12	12	12	12
Resistance 1	12	12	12	12
Pivot Point	12	12	12	12
Support 1	11	12	11	11
Support 2	11	12	11	11
Support 3	11	12	11	11

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Jan 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 51.84%	(0.01) 51.84%	(6.91) 51.84%	(0.01) 44.91%	(0.41) 44.91%	(0.01) 44.53%	(0.01) 44.53%	(-11.31) 44.53%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%
FIIs	(-0.11) 0.50%	(0.01) 0.60%	(0.11) 0.58%	(-0.11) 0.52%	(-0.21) 0.62%	(-0.81) 0.82%	(0.91) 1.65%	(-2.51) 0.73%	(-13.41) 3.24%	(-0.41) 16.60%	(0.91) 16.98%	(0.11) 16.12%	(0.01) 16.02%	(-0.11) 16.00%	(0.11) 16.07%	(-0.11) 15.99%	(14.61) 16.12%	(-0.21) 1.49%	(0.21) 1.67%	(-0.91) 1.52%	(0.01) 2.46%
DIIs	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.00%	(-0.11) 0.00%	(-0.11) 0.08%	(0.01) 0.19%	(0.21) 0.15%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Government	3.75%	4.03%	3.56%	5.84%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.00%	0.00%	0.00%	0.00%
Public	43.90%	43.52%	44.02%	48.73%	54.37%	54.45%	53.64%	54.72%	40.94%	27.57%	27.20%	28.05%	28.17%	28.18%	28.12%	28.20%	28.06%	42.72%	42.53%	42.68%	41.74%
No. of Shareholders	73,834	74,834	76,648	78,124	76,470	71,977	69,241	69,482	66,741	58,230	59,946	60,761	60,283	61,582	62,874	64,422	62,940	63,909	64,012	56,073	55,124

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	0	1	0	1	5	0	0	6	359	441	452	398	394	389	344	389	403	476	443.01	364.57	385.06
Sales Growth % (YoY)	-92%	12800%	-100%	-88%	-99%	-100%	-100%	-99%	-9%	14%	31%	2%	-2%	-18%	-22%	6.6%	4.7%	36.5%	17.2%	-14.8%	-1.2%
Sales Growth % (QoQ)	-100%	100%	-100%	-80%	100%	-	-100%	-98.3%	-18.6%	-2.4%	13.6%	1%	1.3%	13.1%	-11.6%	-3.5%	-15.3%	7.4%	21.5%	-5.3%	-
Expenses	28	59	2	0	6	0	0	6	319	393	410	371	359	371	343	396	361	427	396.43	337.11	349.69
Operating Profit	-27	-57	-2	1	-1	0	0	-1	40	48	42	27	36	18	1	-7	42	49	46.58	27.46	35.37
OPM %	-6198	-4437	0	77	-16	-500	-500	-10	11	11	9	7	9	5	0	-2	10	10	10.51	7.53	9.19
Other Income	3	-24	35	-176	-62	-130	8	7	1	1	0	11	0	18	13	11	0	1	0.53	5.1	5.15
Interest	0	6	30	0	0	0	0	0	20	24	25	21	18	20	17	21	21	17	17.62	18.01	25.75
Depreciation	0	0	0	0	1	0	0	0	15	15	15	15	15	15	15	15	15	14	14.28	14.15	14.28
Profit before tax	-24	-88	3	-176	-64	-130	8	5	5	11	2	2	3	2	-18	-32	6	18	15.21	0.4	0.49
Tax %	-37	-22	-339	0	-1	0	2	-2	40	95	36	38	41	-145	-47	-31	36	35	36.09	-367.5	-265.31
Net Profit	-15	-68	14	-176	-63	-130	8	6	3	1	2	1	2	4	-9	-22	4	12	9.73	1.86	1.79
Net Profit Growth % (QoQ)	77.9%	-585.7%	108%	-179.4%	51.5%	-1725%	33.3%	100%	200%	-50%	100%	-50%	-50%	144.4%	59.1%	-650%	-66.7%	23.3%	423.1%	3.9%	-
Net Profit Growth % (YoY)	76.2%	47.7%	75%	-3033.3%	-2200%	-13100%	300%	500%	50%	-75%	122.2%	104.5%	-50%	-66.7%	-192.5%	-1282.8%	123.5%	-	-	-	-
TTM Net Profit	-245	-293	-355	-361	-179	-113	18	12	7	6	9	-2	-25	-23	-15	3.73	27.59	25.38	13.38	3.65	0
EPS in Rs	-0.79	-3.5	0.64	-7.85	-2.82	-5.8	0.35	0.25	0.13	0.03	0.07	0.05	0.08	0.16	-0.41	-1	0.17	0.52	0.43	0.08	0.08

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	0	1664	1682	1520	1665	1541	2363	2779	1874	1635	1674	1638	1634	1622
Sales Growth %	-100%	-1%	11%	-9%	8%	-35%	-15%	48%	15%	-2%	2%	-	0.7%	23.6%
Expenses	8	1694	1530	1467	1507	1432	2143	2514	1638	1411	1436	1371	1345	1332
Operating Profit	-8	-30	152	53	159	109	220	264	236	224	239	267	289	290
OPM %	-2920	-1.8	9	3.5	10	7	9	10	13	14	14	16	18	18
Other Income	-279	5	15	43	11	-22	4	6	6	23	6	20	12	16
Interest	36	75	87	79	79	112	126	148	115	117	123	126	138	115
Depreciation	0	62	61	59	57	60	61	63	64	62	57	77	84	76
Profit before tax	-323	-162	18	-42	34	-85	37	59	63	67	64	85	78	115
Tax %	-9	-30	73	-43	26	-14	15	19	17	18	15	22	21	25
Net Profit	-293	-114	5	-24	25	-73	32	48	52	55	54	66	62	86
Net Profit Growth %	-157%	-2380%	120.8%	-196%	134.2%	-328.1%	-33.3%	-7.7%	-5.5%	1.9%	-18.2%	6.5%	-27.9%	-
EPS in Rs	-15.08	-5.07	0.22	-1.08	1.12	-3.27	1.42	2.12	2.33	2.47	2.42	2.95	2.77	3.82
Dividend Payout %	0	0	0	0	0	0	4	2	2	2	4	3	4	3

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	-349	169	225	134	95	21	285	239	65	199	169	144	255	361
Cash from Investing Activity	1208	-42	-17	52	17	-29	-33	-26	-29	-18	-77	-60	-90	-99
Cash from Financing Activity	-767	-128	-205	-186	-119	11	-252	-201	-40	-204	-89	-61	-161	-282
Net Cash Flow	93	-1	2	0	-8	4	0	12	-4	-23	3	23	4	-20

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	19	22	22	22	22	22	22	22	22	22	22	22	22	22	22	22
Reserves	563	694	934	1055	1047	1042	1065	1040	1114	1083	1036	984	932	936	905	845
Borrowings	0	459	582	629	636	754	860	903	779	903	955	878	962	925	858	879
Other Liabilities	39	639	509	476	486	371	443	423	718	696	710	696	640	628	609	527
Total Liabilities	622	1815	2047	2183	2191	2189	2391	2388	2633	2705	2724	2581	2556	2510	2394	2274
Fixed Assets	105	28	633	804	643	662	723	772	785	825	852	881	906	934	948	914
CWIP	0	0	57	57	66	78	85	99	115	100	100	102	99	91	122	139
Investments	13	1	1	1	1	1	1	1	0	1	1	1	1	1	0	0
Other Assets	504	1786	1357	1321	1482	1449	1582	1517	1733	1780	1771	1597	1551	1485	1324	1221
Total Assets	622	1815	2047	2183	2191	2189	2391	2388	2633	2705	2724	2581	2556	2510	2394	2274

Delivery

Delivery Data: NECLIFE

#	Date	10 34% 14	Value (Cr)	Q/T 608	Del 79	Del 1
1	4-Sep	12	0	568	83	0
2	3-Sep	12	0	661	76	0
3	2-Sep	12	0	578	68	0
4	1-Sep	12	0	627	83	0
5	31-Aug	13	0	377	75	0
6	28-Aug	12	1	430	62	0
7	27-Aug	13	1	421	67	1
8	26-Aug	12	2	886	79	1
9	25-Aug	11	0	468	77	0
10	24-Aug	11	0	380	87	0
11	21-Aug	10	0	429	64	0
12	20-Aug	10	0	356	84	0
13	19-Aug	11	0	330	63	0
14	18-Aug	11	0	427	75	0
15	17-Aug	11	0	403	96	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	236c	6c	2.57
03-Sep	242c	26c	12.25
14-Aug	216c	5c	2.12
13-Aug	220c	11c	5.19
12-Aug	209c	5c	2.67
11-Aug	204c	2c	0.85
10-Aug	206c	1c	0.57
06-Aug	205c	39L	0.19
04-Aug	205c	3c	1.22
31-Jul	208c	11c	5.64
30-Jul	196c	3c	1.37
29-Jul	199c	97L	0.49
28-Jul	198c	4c	1.92
27-Jul	202c	2c	0.97
24-Jul	200c	0	0

Stock Checklist

Price is above from 52 week high low average: 22%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.00%	-	0

Nectar Lifesciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements